Cesar Santa-Maria

Assistant Professor

20082019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Cesar Santa-Maria is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Aromatase Inhibitors Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Neoadjuvant Therapy Medicine & Life Sciences
letrozole Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

Feasibility and acceptability of intensive longitudinal data collection of activity and patient-reported outcomes during chemotherapy for breast cancer

Solk, P., Gavin, K., Fanning, J., Welch, W., Lloyd, G., Cottrell, A., Nielsen, A., Santa Maria, C. A., Gradishar, W., Khan, S. A., Kulkarni, S., Siddique, J. & Phillips, S. M., Dec 1 2019, In : Quality of Life Research. 28, 12, p. 3333-3346 14 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Drug Therapy
Text Messaging
Aptitude
Wrist

In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model

Wang, H., Milberg, O., Bartelink, I. H., Vicini, P., Wang, B., Narwal, R., Roskos, L., Santa-Maria, C. & Popel, A. S., May 1 2019, In : Royal Society Open Science. 6, 5, 190366.

Research output: Contribution to journalArticle

Open Access
Computer Simulation
Immunotherapy
Clinical Trials
Pharmacology
Breast Neoplasms

Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer

Mutonga, M., Speedy, S., Rademaker, A., Liu, D., Uthe, R., Jain, S., Gradishar, W. J., Flaum, L. & Santa-Maria, C., Jan 1 2019, In : Breast Cancer Research and Treatment.

Research output: Contribution to journalArticle

Breast Neoplasms
Gene Expression
Recurrence
Progesterone Receptors
Adjuvant Chemotherapy

Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer

Paplomata, E., Zelnak, A., Santa-Maria, C., Liu, Y., Gogineni, K., Li, X., Moreno, C. S., Chen, Z., Kaklamani, V. & O'Regan, R. M., Jan 1 2019, In : Clinical Breast Cancer.

Research output: Contribution to journalArticle

Hormones
Breast Neoplasms
Therapeutics
Disease-Free Survival
Disease Progression

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

Santa-Maria, C., Bardia, A., Blackford, A. L., Snyder, C., Connolly, R., Fetting, J. H., Hayes, D. F., Jeter, S. C., Miller, R. S., Nguyen, A., Quinlan, K., Rosner, G., Slater, S., Storniolo, A. M., Wolff, A. C., Zorzi, J., Henry, N. L. & Stearns, V., May 11 2018, (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-9 9 p.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Aromatase Inhibitors
exemestane
Pharmacogenetics